Related Experiment Video

Updated: May 6, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

16.1K

Role of STAT3 in cancer metastasis and translational advances

Mohammad Zahid Kamran1, Prachi Patil, Rajiv P Gude

  • 1Gude lab, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, India.

Biomed Research International
|November 8, 2013
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) is crucial in cancer. This review details STAT3 regulation, its role in cancer metastasis, and emerging small molecule inhibitors targeting this pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is a transcription factor.
  • STAT3 activation involves tyrosine phosphorylation, dimerization, and nuclear translocation.
  • STAT3 is tightly regulated in normal physiology but constitutively activated in many cancers.

Purpose of the Study:

  • To describe the mechanism of STAT3 regulation.
  • To elucidate the role of STAT3 in cancer metastasis.
  • To summarize small molecule inhibitors of STAT3 signaling.

Main Methods:

  • Literature review of STAT3 regulation mechanisms.
  • Analysis of STAT3's involvement in cancer progression.
  • Compilation of data on STAT3-targeting small molecule inhibitors.

Main Results:

  • STAT3 regulates key processes in cancer metastasis, including proliferation, invasion, migration, and angiogenesis.
  • Constitutive STAT3 activation is implicated in tumor growth and spread.
  • Various small molecule inhibitors targeting STAT3 signaling pathways have been identified.

Conclusions:

  • STAT3 is a critical mediator of cancer metastasis.
  • Targeting STAT3 signaling presents a promising therapeutic strategy for cancer treatment.
  • Further research into STAT3 inhibitors is warranted for clinical application.

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K
Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells09:32

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

8.4K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K